Back to dashboard
MedicaidAdministrativeMedium impact

Removal of the DATA Waiver (X-Waiver) Requirement for Practitioners Prescribing Buprenorphine

Illinois Medicaid - HFS·IL · Family Medicine, Internal Medicine, Psychiatry +2 more·Provider Notice
Effective date
Feb 23, 2023
We identified it
Jun 20, 2026
Days to comply

Summary

The federal X-Waiver requirement for practitioners to prescribe buprenorphine for opioid use disorder treatment has been eliminated. All practitioners with DEA Schedule III authority can now prescribe buprenorphine without special waivers or patient limits.

Action Required

Action needed
Immediately: Notify providers that X-Waiver is no longer required for buprenorphine prescribing. Update internal documentation and provider education materials to reflect removal of patient limits. Ensure billing staff understand that buprenorphine prescriptions from providers without X-Waivers are now valid for processing.